Published in ACS Omega on August 24, 2016
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science (2005) 23.44
Dose translation from animal to human studies revisited. FASEB J (2007) 15.67
Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov (2008) 12.72
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett (2006) 10.12
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A (1978) 6.55
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol (1999) 5.67
Effect of surface properties on nanoparticle-cell interactions. Small (2010) 4.98
Hyperthermia in combined treatment of cancer. Lancet Oncol (2002) 4.41
Nanoparticle delivery of cancer drugs. Annu Rev Med (2011) 3.75
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev (2013) 3.44
Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater (2009) 2.85
The inflammatory response to cell death. Annu Rev Pathol (2008) 2.85
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res (2010) 2.70
Evaluation of 4-(2-hydroxyethyl)-1-piperazineëthanesulfonic acid (HEPES) as a tissue culture buffer. Proc Soc Exp Biol Med (1969) 2.65
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine (2012) 2.29
Hyperthermia in oncology. Int J Hyperthermia (2001) 2.27
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine (2011) 2.09
Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol (2015) 2.08
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative. J Clin Oncol (1996) 1.97
Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics (2004) 1.92
Plasmon resonances of a gold nanostar. Nano Lett (2007) 1.71
MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Biomaterials (2011) 1.71
Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim Biophys Acta (1980) 1.66
Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents. Ann Oncol (2012) 1.64
Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia (2005) 1.56
Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release (2001) 1.54
Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics (2011) 1.53
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta (1986) 1.52
Triple-negative breast cancer: role of specific chemotherapy agents. Cancer J (2010) 1.51
Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano (2011) 1.48
Liposome: classification, preparation, and applications. Nanoscale Res Lett (2013) 1.41
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res (2012) 1.38
Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol Pharm (2010) 1.36
Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv Drug Deliv Rev (2013) 1.33
Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys (1996) 1.32
Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA. ACS Nano (2012) 1.30
Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine (Lond) (2010) 1.28
Gold nanoparticles delivery in mammalian live cells: a critical review. Nano Rev (2010) 1.25
Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano (2011) 1.25
Subtyping of triple-negative breast cancer: implications for therapy. Cancer (2014) 1.21
Molecular basis of triple negative breast cancer and implications for therapy. Int J Breast Cancer (2011) 1.19
Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia. J Control Release (2010) 1.19
Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. Biochim Biophys Acta (1998) 1.18
Nanoparticles for photothermal therapies. Nanoscale (2014) 1.18
The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy. Mol Pharm (2011) 1.16
Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer. Open Nanomed J (2011) 1.14
Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. Bioconjug Chem (2009) 1.12
Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: a phase I/II trial. Clin Cancer Res (2002) 1.08
Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours. Int J Hyperthermia (2010) 1.08
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. J Control Release (2013) 1.05
Thermal therapy, part 2: hyperthermia techniques. Crit Rev Biomed Eng (2006) 1.01
Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery (2002) 1.00
Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU). J Control Release (2013) 0.97
Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia. Biomaterials (2012) 0.97
Emerging advances in nanomedicine with engineered gold nanostructures. Nanoscale (2014) 0.96
Thermosensitive liposomal drug delivery systems: state of the art review. Int J Nanomedicine (2014) 0.96
The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin (2015) 0.94
Thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for triggered release of doxorubicin. Biomacromolecules (2010) 0.92
Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. J Mater Chem (2010) 0.90
Materials characterization of the low temperature sensitive liposome (LTSL): effects of the lipid composition (lysolipid and DSPE-PEG2000) on the thermal transition and release of doxorubicin. Faraday Discuss (2013) 0.89
One-step fabrication of self-assembled peptide thin films with highly dispersed noble metal nanoparticles. Langmuir (2013) 0.88
Conjugation of Kahalalide F with gold nanoparticles to enhance in vitro antitumoral activity. Bioconjug Chem (2009) 0.88
Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases. Theranostics (2015) 0.87
Elucidating the fundamental mechanisms of cell death triggered by photothermal therapy. ACS Nano (2015) 0.87
Gold Nanorod-pNIPAM Hybrids with Reversible Plasmon Coupling: Synthesis, Modeling, and SERS Properties. ACS Appl Mater Interfaces (2015) 0.86
Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials (2013) 0.86
A gold nanoshell with a silica inner shell synthesized using liposome templates for doxorubicin loading and near-infrared photothermal therapy. Int J Nanomedicine (2011) 0.86
Treating cancer with heat: hyperthermia as promising strategy to enhance apoptosis. J Pak Med Assoc (2013) 0.84
Drug-loaded gold/iron/gold plasmonic nanoparticles for magnetic targeted chemo-photothermal treatment of rheumatoid arthritis. Biomaterials (2015) 0.80
Hyperthermia engages the intrinsic apoptotic pathway by enhancing upstream caspase activation to overcome apoptotic resistance in MCF-7 breast adenocarcinoma cells. J Cell Biochem (2006) 0.80
Multidrug-resistant hela cells overexpressing MRP1 exhibit sensitivity to cell killing by hyperthermia: interactions with etoposide. Int J Radiat Oncol Biol Phys (2004) 0.79
Monolayers of gold nanostars with two near-IR LSPRs capable of additive photothermal response. Chem Commun (Camb) (2015) 0.78
Adjusting the Metrics of 1-D Helical Gold Nanoparticle Superstructures Using Multivalent Peptide Conjugates. Langmuir (2015) 0.78
Triggered doxorubicin release in solid tumors from thermosensitive liposome-peptide hybrids: Critical parameters and therapeutic efficacy. Int J Cancer (2015) 0.78
Advances in hyperthermia technology. Conf Proc IEEE Eng Med Biol Soc (2005) 0.76
Molecular mechanisms of apoptosis activation by heat shock in multidrug-resistant Chinese hamster cells. Radiat Res (2008) 0.76